Cargando…
Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) has been associated with cardiac abnormalities including mitral valve prolapse and aneurysmal dilatation of the aortic root. Herein, we investigated the potential association of pericardial effusion with ADPKD. Subjects with ADPKD (n = 117) and co...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879333/ https://www.ncbi.nlm.nih.gov/pubmed/35207400 http://dx.doi.org/10.3390/jcm11041127 |
_version_ | 1784658873912655872 |
---|---|
author | Liu, Jin Fujikura, Kana Dev, Hreedi Riyahi, Sadjad Blumenfeld, Jon Kim, Jiwon Rennert, Hanna Prince, Martin R. |
author_facet | Liu, Jin Fujikura, Kana Dev, Hreedi Riyahi, Sadjad Blumenfeld, Jon Kim, Jiwon Rennert, Hanna Prince, Martin R. |
author_sort | Liu, Jin |
collection | PubMed |
description | Autosomal dominant polycystic kidney disease (ADPKD) has been associated with cardiac abnormalities including mitral valve prolapse and aneurysmal dilatation of the aortic root. Herein, we investigated the potential association of pericardial effusion with ADPKD. Subjects with ADPKD (n = 117) and control subjects without ADPKD matched for age, gender and renal function (n = 117) undergoing MRI including ECG-gated cine MRI of the aorta and heart were evaluated for pericardial effusion independently by three observers measuring the maximum pericardial effusion thickness in diastole using electronic calipers. Pericardial effusion thickness was larger in ADPKD subjects compared to matched controls (Mann–Whitney p = 0.001) with pericardial effusion thickness >5 mm observed in 24 of 117 (21%) ADPKD subjects compared to 4 of 117 (3%) controls (p = 0.00006). Pericardial effusion thickness in ADPKD was associated with female gender patients (1.2 mm greater than in males, p = 0.03) and pleural effusion thickness (p < 0.001) in multivariate analyses. No subjects exhibited symptoms related to pericardial effusion or required pericardiocentesis. In conclusion, pericardial effusion appears to be more prevalent in ADPKD compared to controls. Although in this retrospective cross-sectional study we did not identify clinical significance, future investigations of pericardial effusion in ADPKD subjects may help to more fully understand its role in this disease. |
format | Online Article Text |
id | pubmed-8879333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88793332022-02-26 Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease Liu, Jin Fujikura, Kana Dev, Hreedi Riyahi, Sadjad Blumenfeld, Jon Kim, Jiwon Rennert, Hanna Prince, Martin R. J Clin Med Article Autosomal dominant polycystic kidney disease (ADPKD) has been associated with cardiac abnormalities including mitral valve prolapse and aneurysmal dilatation of the aortic root. Herein, we investigated the potential association of pericardial effusion with ADPKD. Subjects with ADPKD (n = 117) and control subjects without ADPKD matched for age, gender and renal function (n = 117) undergoing MRI including ECG-gated cine MRI of the aorta and heart were evaluated for pericardial effusion independently by three observers measuring the maximum pericardial effusion thickness in diastole using electronic calipers. Pericardial effusion thickness was larger in ADPKD subjects compared to matched controls (Mann–Whitney p = 0.001) with pericardial effusion thickness >5 mm observed in 24 of 117 (21%) ADPKD subjects compared to 4 of 117 (3%) controls (p = 0.00006). Pericardial effusion thickness in ADPKD was associated with female gender patients (1.2 mm greater than in males, p = 0.03) and pleural effusion thickness (p < 0.001) in multivariate analyses. No subjects exhibited symptoms related to pericardial effusion or required pericardiocentesis. In conclusion, pericardial effusion appears to be more prevalent in ADPKD compared to controls. Although in this retrospective cross-sectional study we did not identify clinical significance, future investigations of pericardial effusion in ADPKD subjects may help to more fully understand its role in this disease. MDPI 2022-02-21 /pmc/articles/PMC8879333/ /pubmed/35207400 http://dx.doi.org/10.3390/jcm11041127 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Jin Fujikura, Kana Dev, Hreedi Riyahi, Sadjad Blumenfeld, Jon Kim, Jiwon Rennert, Hanna Prince, Martin R. Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease |
title | Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease |
title_full | Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease |
title_fullStr | Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease |
title_full_unstemmed | Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease |
title_short | Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease |
title_sort | pericardial effusion on mri in autosomal dominant polycystic kidney disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879333/ https://www.ncbi.nlm.nih.gov/pubmed/35207400 http://dx.doi.org/10.3390/jcm11041127 |
work_keys_str_mv | AT liujin pericardialeffusiononmriinautosomaldominantpolycystickidneydisease AT fujikurakana pericardialeffusiononmriinautosomaldominantpolycystickidneydisease AT devhreedi pericardialeffusiononmriinautosomaldominantpolycystickidneydisease AT riyahisadjad pericardialeffusiononmriinautosomaldominantpolycystickidneydisease AT blumenfeldjon pericardialeffusiononmriinautosomaldominantpolycystickidneydisease AT kimjiwon pericardialeffusiononmriinautosomaldominantpolycystickidneydisease AT rennerthanna pericardialeffusiononmriinautosomaldominantpolycystickidneydisease AT princemartinr pericardialeffusiononmriinautosomaldominantpolycystickidneydisease |